Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Irish Journal of Medical Science|December 6, 2025
Nitrous oxide abuse: single centre experience of nitrous oxide induced myeloneuropathyAine Redmond, Smitha Samuel, Marie Ryan, et al.JTO Clinical and Research Reports|September 30, 2021
Intracranial Complications From Immune Checkpoint Therapy in a Patient With NSCLC and Multiple Sclerosis: Case ReportBenjamin Y Lu, Cigdem Isitan, Amit Mahajan, et al.BMJ Open Gastroenterology|May 6, 2022
Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver diseaseSara Naimimohasses, Philip O'Gorman, Emma McCormick, et al.Journal of the Academy of Consultation-Liaison Psychiatry|February 19, 2025
Developing a Clinical Workflow for Early Recognition and Diagnosis of Autoimmune Encephalitis in Patients Presenting With Atypical PsychosisGrace Russo, Lucy Jia, Carla Y Kim, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 10, 2025
Accelerated long-term forgetting as a predictor of clinical onset in presymptomatic autosomal dominant Alzheimer's diseaseNicholas Magill, Rachana Tank, Damien Ferguson, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 11, 2022
Axicabtagene Ciloleucel in Patients Ineligible for ZUMA-1 Because of CNS Involvement and/or HIV: A Multicenter ExperienceCarlen A Yuen, Jing-Mei Hsu, Koen Van Besien, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 23, 2026
The relative contribution of modifiable and non-modifiable factors for determining cognition in mid-life individuals at risk for late-life Alzheimer's diseaseBolin Cao, Qing Qi, Siobhan Hutchinson, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsNicholas Magill, Christopher S Parker, Chloe Young, et al.Journal of Viral Hepatitis|December 29, 2020
Improvement in cognitive impairment following a 12-week aerobic exercise intervention in individuals with non-cirrhotic chronic hepatitis CPhilip O'Gorman, Orla Strahan, Damien Ferguson, et al.Multiple Sclerosis and Related Disorders|December 19, 2021
Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability DataSamantha Epstein, Zongqi Xia, Annie J Lee, et al.Pageof 3